Approval · Notice of Compliance 9629 · 2008
TEMODAL: Notice of Compliance 9629
Issued June 18, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9629
- Date
- June 18, 2008
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths: 140 mg and 180 mg
- Therapeutic class
- Antineoplastic agent
Products in this notice
Medicinal ingredients
- TEMOZOLOMIDE 180 MG per CAP
- TEMOZOLOMIDE 140 MG per CAP